Clinical trial
Prospective Open Label Clinical and Genetic Testing of Patients With Retinitis Pigment
NCT03901391 is registered in ClinicalTrials.gov with Sensor Technology for Deafblind as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Open Label Clinical and Genetic Testing of Patients With Retinitis Pigment
- Lead sponsor
- Sensor Technology for Deafblind
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 26, 2019
- Completion date
- October 20, 2020
- Enrollment
- 130 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.